ScopusElsevier Scopus
Status
Inactive/Discontinued
Coverage
2019 (also 2017)
Source type
Journal
Open access
No
Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Multiple Sclerosis and Demyelinating Disorders
Multiple Sclerosis and Demyelinating Disorders is not currently indexed in Scopus. Published by BioMed Central Ltd.
Checked against the index lists dated .
ISSN 2056-6115Verify ISSN ↗
Publisher: BioMed Central Ltd
Scopus · Inactive
0
Indexed in
Cost to publish: About US$1,990 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
DOAJDirectory of Open Access Journals (live)
Not in DOAJ
Open accessNot registered as fully open access
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Quick answers
Is Multiple Sclerosis and Demyelinating Disorders indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2019 (also 2017)).
What is the impact factor of Multiple Sclerosis and Demyelinating Disorders?
Multiple Sclerosis and Demyelinating Disorders has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
How much does it cost to publish in Multiple Sclerosis and Demyelinating Disorders?
The publisher lists an article processing charge of about US$1,990 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Who publishes Multiple Sclerosis and Demyelinating Disorders and what is its ISSN?
Multiple Sclerosis and Demyelinating Disorders is published by BioMed Central Ltd. Its ISSN is 2056-6115.
Is Multiple Sclerosis and Demyelinating Disorders in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Multiple Sclerosis and Demyelinating Disorders open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Multiple Sclerosis and Demyelinating Disorders for 2 years, between 2017 and 2019, with 1 year in that span missing. Coverage ended in 2019, 7 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 37 works and 470 citations for the title. Its most recent paper is from 2019, in line with the end of Scopus coverage in 2019, which suggests the journal stopped publishing around then.
How well cited is Multiple Sclerosis and Demyelinating Disorders? — open metrics via OpenAlex
Multiple Sclerosis and Demyelinating Disorders has an h-index of 12 and a 2-year mean of 0 citations per paper (OpenAlex).
12
h-index
0
2-yr mean citations
16
i10-index
37
works indexed
470
total citations
Publication fee · open access list price, US$
US$1,990
Multiple Sclerosis and Demyelinating Disorders published 3 papers in 2019; its busiest recent year was 2016 with 15. 2026* is the year so far.
Main topics
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Multiple Sclerosis and Demyelinating Disorders? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2019. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2019
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from BioMed Central Ltd
BioMed Central Ltd has 338 other titles in our data; 251 are currently indexed in Scopus.
Related journals
8 journals Journal Indexed in
Neural Development DOAJ Nonlinear Biomedical Physics Not in these indexes Nuclear Receptor Not in these indexes Nutrition and Metabolism Not in these indexes Nutrition and Metabolism Scopus Q1 WoS SCIE DOAJ Nutrition Journal Scopus Q1 WoS SCIE DOAJ Organic and Medicinal Chemistry Letters Not in these indexes Orphanet Journal of Rare Diseases Scopus Q2 WoS SCIE DOAJ
← Back to Journal Finder
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.